As I have been saying with my previous posts Relenza is going to be THE ONLY ANTIVIRAL drug currently in the market to help fighting certain strains of flu and the almighty birdflu.
The writing is on the wall and the latest announcement from GSK sending more Relenza to Japan underwrites this sentiment. Tamiflu will soon be history and Relenza the drug of choice fighting certain flu strains.
So good to see that this drug still get its place in history before the patent runs out, and it will be able to make some real good money for the next 5 years.
Still not to late to jump into Biota not only for Relenza but for Lani and the other blockbuster drugs in the pipe line.
jojo
BTA Price at posting:
47.0¢ Sentiment: LT Buy Disclosure: Held